Short answer
Prestige Consumer Healthcare Inc. (PBH) filed an 8-K current report with the SEC on August 6, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Fiscal Q1 2026 results cover the quarter ended June 30, 2026.
Prestige Consumer Healthcare Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Fiscal Q1 2026 results cover the quarter ended June 30, 2026
- Earnings press release issued August 6, 2026
- Detailed financial results and management commentary in Exhibit 99.1
Item 7.01 · Regulation FD Disclosure
- Investor Presentation disclosed under Regulation FD, with substantive content in Exhibits 99.1 and 99.2
- Presentation information supplemental to SEC filings and other public announcements
- Information generally not “filed” under Exchange Act Section 18, limiting liability exposure for the company
- No obligation to update presentation materials, potentially limiting ongoing investor guidance不卡无码
Item EX-99.1 · Exhibit EX-99.1
- Q1 FY2027 revenue $265.7M, up 6.5%, with organic growth 3.2% exceeding expectations
- Adjusted EPS $0.98 versus $0.95, while GAAP EPS fell to $0.61 amid acquisition and facility-remediation costs
- Breathe Right and LaCorium acquisitions add nearly 20% to revenue base, with integration costs pressuring near-term earnings
- FY2027 outlook raised to revenue $1,290–$1,315M, adjusted EPS $4.55–$4.65, and adjusted free cash flow $270M or more
- Net debt approximately $2B, but refinancing $400M at 6.25% extends maturities to 2034 and moves closest debt maturity to 2031
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Prestige Consumer Healthcare Inc. 8-K filings
Get the next PBH 8-K as it lands
Follow PBH for push alerts, or ask the research agent what this filing means.